Write in a clean editor, then format for Liver Cancer International in one click — DocuGuru applies the official Wiley template with author–year references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
Liver Cancer International is a peer-reviewed journal published by Wiley, covering Hepatocellular Carcinoma Treatment and Prognosis, Liver Disease Diagnosis and Treatment, Cholangiocarcinoma and Gallbladder Cancer Studies.
| Publisher | Wiley |
|---|---|
| Reference style | Author–year (Chicago) Author–year — (Smith, 2023) in the text Smith, Ada, Ben Jones, and Cara Lee. 2023. "A Representative Article Title." Liver Cancer International 12 (3): 45–58.
Formats any DOI in Liver Cancer International style. No sign-up. |
| Publishes research in | Hepatocellular Carcinoma Treatment and Prognosis Liver Disease Diagnosis and Treatment Cholangiocarcinoma and Gallbladder Cancer Studies Ferroptosis and cancer prognosis Cancer, Lipids, and Metabolism |
| ISSN | 2642-3561 |
| h-index | 7 |
| i10-index | 3 |
| Total citations | 201 |
| Open access | Yes |
| Top institutions publishing here | Imperial College London |
| Journal website | onlinelibrary.wiley.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Citations each year’s papers have accumulated so far — the most recent years are still building up.
BACKGROUND: Hepatocellular carcinoma (HCC) is a leading causes of cancer mortality worldwide. Improved tools are needed for detecting HCC so that treatment can begin as early as possible. Current diagnostic approaches and existing biomarkers, such as alpha-fetoprotein (AFP) lack sensitivity, resulting in too many false negative diagnoses. Machine-learning may be able to identify combinations of…
Abstract Aflatoxins are produced by Aspergillus flavus and Aspergillus parasiticus and are toxic carcinogens. These ‘fungal molds’ grow on corn, groundnuts, cereals and other grains. Of all the aflatoxins, Aflatoxin‐B1 (AFB1) is considered the most toxic. Long‐term exposure of AFB1 forms DNA adducts causing many genetic mutations and epigenetic alterations, ultimately leading to hepatocellular carcinoma…
Abstract Background and Aims Biliary tract cancer (BTC) represents a major public health problem due to its increasing rates of incidence and mortality, especially the intrahepatic cholangiocarcinoma (IHCCA) subtype. First line palliative systemic treatment with cisplatin and gemcitabine has been the unique level IA evidence option until last few years when a deeper understanding of…
Treatment allocation of patients with hepatocellular carcinoma (HCC) is an extremely complex process as this tumour usually arises in patients with liver cirrhosis, that may be complicated by features of portal hypertension and liver failure, and patients often present additional comorbidities, thus making the therapeutic decision process even more challenging.1 The complexity of this scenario…
Abstract Hepatocellular carcinoma (HCC) is a heterogeneous disease that often features dysregulated tumour lipid metabolism. ACSL3 and ACSL4 are two homologous long chain acyl‐coenzyme A synthetases (ACSL) that preferentially catalyse the activation of monounsaturated and polyunsaturated fatty acids, respectively. Both enzymes are frequently overexpressed in HCC, and multiple reports have implicated ACSL4 in tumour progression.…
